15 September 2015 - Below is a list of forthcoming submissions that have recently been added to the SMC work programme. Information in relation to the drug indication, the date SMC advice is due to be published, as well as the deadline date for a Patient Group Submission, may be viewed on the SMC website.

Recently added forthcoming submissions:

• Camellia sinensis (green tea leaf (Catephen)
• Dinutuximab (Unituxin)
• Eculizumab (Soliris)
• Golimumab (Simponi)
• Guanfacine hydrochloride (Intuniv)
• Isavuconazole (Cresemba)
• Nivolumab (Opdivo)
• Panobinostat lactate (Farydak)
• Pertuzumab (Perjeta)
• Ulipristal acetate (Esmya)
• Ustekinumab (Stelara)

For more details, go to: http://www.scottishmedicines.org.uk/SMC_Advice/Forthcoming_Submissions/Forthcoming_Submissions?iru=2ICSSBDQBC